The NHL Alumni Association has signed a landmark agreement with Canopy Growth Corp., that will see the Canadian cannabis company finance one or more studies that could be an important step towards establishing the first comprehensive snapshot of the health of retired hockey players. Canopy Growth has agreed to cover the costs of a double …
Neeka Health Canada (NHC) is the Canadian clinical subsidiary of Neeka Enterprises (NE) that is built on the scientific underpinnings of research by Dr. Amin Kassam and Dr. Rich Rovin.
With over four decades of experience, along with the broader NHC team, they provide experience in multiple domains, including: clinical trial design, molecular cell signaling and cell engineering, bioinformatics and patient-empowered and patient-owned data management digital health systems to transform the lives of patients suffering from post-concussion neurological diseases.
Concussion and Cannabinoids Research
CANOPY GROWTH CORPORTATION, NATIONAL HOCKEY LEAGUE ALUMNI ASSOCIATION and NEEKA HEALTH CANADA CANNABINOID COLLABORATION:
To study the impact of incorporating cannabinoids into a specific treatment protocol for elite athletes suffering from “concussion syndrome” and their ability to functionally integrate into their world.
Click here to view the Official Press Release
Canopy Growth Corporation (CGC) and Neeka Health Canada (NHC), in partnership with National Hockey League Alumni Association (NHLAA), is undertaking a transformative clinical research effort that features an elite cohort of individuals, many of whom are Canadian sports heroes and household names for most of us!
Functional Integration:
Some of these, once high performing elite athletes, have developed progressive neurocognitive impairments representing a constellation of conditions ranging from depression, post-traumatic stress disorders (PTSD) and progressive dementia from chronic traumatic encephalopathy (CTE); historically, these have clustered together into a nebulous and ill-defined syndrome called “concussion”. The culmination of these mental health impairments results in debilitating limitations in their ability to cope with their environment and integrate with their world, a term we have coined as “functional integration” of an individual into society. This can result undue stress on their family and support network and may even lead to reliance on medication and opioids as a coping mechanism.
These mental health and neurocognitive conditions are not restricted exclusively to this group; but rather, the NHLAA represent an ideal cohort for this effort, given that they are a highly afflicted population with accelerated issues, the treatment of which could help many others. The lessons from this high risk and highly impacted population would be directly applicable to those in our community suffering from similar, albeit milder, mental health conditions.
In short, this functional integration (“concussion”) research collaboration between Canopy Growth, Neeka Health Canada and the NHLAA is considered a true legacy project, not only for the elite athletes, but also for our broader community with potential hope for friends and family that are also impacted.